Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.

Biotechnology

Lonza

Albert M. Baehny

Ulrike Kaeppler

Michael Nashed

Silvia Schaub

Caroline Barth

Bob Schellinger

Philippe Deecke

Maria Soler Nunez

Jean-Christophe Hyvert

Gordon Bates

Daniel Palmacci

The current leadership team at Lonza has experience working in various finance positions at Novartis, Sandoz, and Alcon. They hold degrees from ETH Zürich and Cornell Johnson Graduate School of Management in economics, finance, and management.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Lonza

Board of Directors

CEO and Executive Team